R&D Pipeline
7 compounds matching your criteria| Compound/indication | Phase 1 | Phase 2 | Phase 3 | Filed | |||
| rFXIII Congenital deficiency Haemostatic agent | ![]() ![]() ![]() ![]() |
||||||
| rFVIII Haemostatic agent | ![]() ![]() ![]() ![]() |
||||||
| Fast-acting rFVIIa analogue Haemostatic agent | ![]() ![]() ![]() ![]() |
||||||
| rFXIII Cardiac surgery Haemostatic agent | ![]() ![]() ![]() ![]() |
||||||
| Long-acting rFVIIa derivative Haemostatic agent | ![]() ![]() ![]() ![]() |
||||||
| Long-acting rFIX derivative Haemostatic agent | ![]() ![]() ![]() ![]() |
||||||
| Subcutaneous, long-acting, rFVIIa derivative Haemostatic agent | ![]() ![]() ![]() ![]() |
||||||





